OBJECTIVES: We sought to examine, in a rural county in the West of Ireland, the degree of familial relationship between schizophrenia and other nonaffective psychoses and affective illness (AI). DESIGN: A case-controlled epidemiologic family study using DSM-III-R criteria. PARTICIPANTS: This study included three proband groups: (1) all cases with a clinical diagnosis of schizophrenia from the Roscommon County Case Register born from 1930 onward (n = 285); (2) a random sample of cases from the register with a clinical diagnosis of severe AI (n = 99); and (3) a matched, random sample of Roscommon residents ascertained from the electoral register (n = 150). Face-to-face structured interviews were conducted with 86% of traceable, living relatives (n = 1, 753) and 88% of traceable, living probands (n = 415). RESULTS: In interviewed relatives, the lifetime risks (+/- SE) for schizophrenia, as a function of the "blind" proband diagnosis, were as follows: schizophrenia, 6.5% +/- 1.6%; schizoaffective disorder, 6.8% +/- 2.5%; schizotypal personality disorder, 6.9% +/- 3.9%; other nonaffective psychoses, 5.1% +/- 2.4%; psychotic AI, 2.8% +/- 1.2%; nonpsychotic AI, 0.6% +/- 0.6%; and control, 0.5% +/- 0.3%. Individuals with schizophrenia reproduced at a rate about one quarter that of controls and the risk for schizophrenia in parents of probands was much less than that found in siblings. CONCLUSIONS: These results support the following hypotheses: (1) in the West of Ireland, as in other populations, schizophrenia is a strongly familial disorder; (2) schizophrenia shares a familial predisposition with a spectrum of clinical syndromes that includes schizoaffective disorder, other nonaffective psychoses, schizotypal personality disorder, and probably psychotic AI, but not nonpsychotic AI; and (3) the diminished reproductive rates associated with schizophrenia have a large impact on the pattern of risk of illness in relatives.
OBJECTIVES: We sought to examine, in a rural county in the West of Ireland, the degree of familial relationship between schizophrenia and other nonaffective psychoses and affective illness (AI). DESIGN: A case-controlled epidemiologic family study using DSM-III-R criteria. PARTICIPANTS: This study included three proband groups: (1) all cases with a clinical diagnosis of schizophrenia from the Roscommon County Case Register born from 1930 onward (n = 285); (2) a random sample of cases from the register with a clinical diagnosis of severe AI (n = 99); and (3) a matched, random sample of Roscommon residents ascertained from the electoral register (n = 150). Face-to-face structured interviews were conducted with 86% of traceable, living relatives (n = 1, 753) and 88% of traceable, living probands (n = 415). RESULTS: In interviewed relatives, the lifetime risks (+/- SE) for schizophrenia, as a function of the "blind" proband diagnosis, were as follows: schizophrenia, 6.5% +/- 1.6%; schizoaffective disorder, 6.8% +/- 2.5%; schizotypal personality disorder, 6.9% +/- 3.9%; other nonaffective psychoses, 5.1% +/- 2.4%; psychotic AI, 2.8% +/- 1.2%; nonpsychotic AI, 0.6% +/- 0.6%; and control, 0.5% +/- 0.3%. Individuals with schizophrenia reproduced at a rate about one quarter that of controls and the risk for schizophrenia in parents of probands was much less than that found in siblings. CONCLUSIONS: These results support the following hypotheses: (1) in the West of Ireland, as in other populations, schizophrenia is a strongly familial disorder; (2) schizophrenia shares a familial predisposition with a spectrum of clinical syndromes that includes schizoaffective disorder, other nonaffective psychoses, schizotypal personality disorder, and probably psychotic AI, but not nonpsychotic AI; and (3) the diminished reproductive rates associated with schizophrenia have a large impact on the pattern of risk of illness in relatives.
Authors: C C Dickey; M E Shenton; Y Hirayasu; I Fischer; M M Voglmaier; M A Niznikiewicz; L J Seidman; S Fraone; R W McCarley Journal: Am J Psychiatry Date: 2000-01 Impact factor: 18.112
Authors: Pamela DeRosse; George C Nitzburg; Toshikazu Ikuta; Bart D Peters; Anil K Malhotra; Philip R Szeszko Journal: Schizophr Bull Date: 2014-11-11 Impact factor: 9.306
Authors: Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Melissa Frumin; Sarah Toner; Susan Demeo; Martha E Shenton Journal: Schizophr Res Date: 2003-11-01 Impact factor: 4.939
Authors: James J Levitt; Robert W McCarley; Chandlee C Dickey; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Yoshio Hirayasu; Aleksandra A Ciszewski; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton Journal: Am J Psychiatry Date: 2002-07 Impact factor: 18.112
Authors: Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Melissa Frumin; Margaret A Niznikiewicz; Yoshio Hirayasu; Stephanie Fraone; Larry J Seidman; Martha E Shenton Journal: Am J Psychiatry Date: 2002-09 Impact factor: 18.112
Authors: Suzanne N Avery; Lisa E Williams; Austin A Woolard; Stephan Heckers Journal: Eur Arch Psychiatry Clin Neurosci Date: 2013-09-11 Impact factor: 5.270
Authors: Ronald J Gurrera; Chandlee C Dickey; Margaret A Niznikiewicz; Martina M Voglmaier; Martha E Shenton; Robert W McCarley Journal: Schizophr Res Date: 2005-09-15 Impact factor: 4.939